Igenica, Inc. To Present New Data At The World ADC Summit

Published: Feb 13, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BURLINGAME, Calif.--(BUSINESS WIRE)--Igenica, Inc., a company focused on the discovery and development of innovative antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that it will present insights into its proteomic target discovery platform and ADC technology during a plenary session of the World ADC meeting, being held February 17-20 in Frankfurt, Germany.

Help employers find you! Check out all the jobs and post your resume.

Back to news